Lung
-
Meta Analysis
Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis.
Several new treatments for severe asthma have become available in the last decade; yet, little data exist to guide their use in specific patient populations. ⋯ Benralizumab, dupilumab, mepolizumab, and reslizumab are all associated with decreased asthma exacerbations in patients with eosinophilic asthma, with no significant inter-drug differences.